Condition: Catheter-Related Infections · Sponsor: CorMedix
This study is a post-marketing approval requirement to assess the safety and time to Catheter-related Bloodstream Infections (CRBSI) of DefenCath in pediatric population (birth to less than 18 years of age) who are on chronic HD for kidney failure.
This description comes directly from the study's public registry record.
Liz Hurlburt · 9085179500 · lhurlburt@cormedix.com
Always discuss trial participation with your own doctor first.
| Children's of Alabama/University of Alabama | Birmingham, Alabama, United States | Recruiting |
| Phoenix Children's Hospital | Phoenix, Arizona, United States | Recruiting |
| Stanford | Palo Alto, California, United States | Recruiting |
| Nemours Children's Hospital - DE | Wilmington, Delaware, United States | Recruiting |
| Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| Cook Children's Health Care System | Fort Worth, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06714864